Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Criteo’s Agreement With Ernst Teunissen for its Board of Directors
Skadden advised Criteo S.A. on the transaction. Criteo S.A., the commerce media company, announced the nomination of Ernst Teunissen to stand for election to its Board...
Waldencast’s $1.2 Billion Business Combination With Obagi and Milk Makeup
Skadden, Arps, Slate, Meagher & Flom represented Waldencast. Latham & Watkins, working alongside Conyers and Nixon Peabody, represented Obagi, and Goodwin Procter represented Milk Makeup in...
Virgin Orbit’s Merger With NextGen Acquisition Corp. II
Skadden, Arps, Slate, Meagher & Flom advised NextGen Acquisition Corp. II, while Latham & Watkins advised Virgin Orbit in the deal. Sullivan & Cromwell represented the...